about
Nanoparticulate adjuvants and delivery systems for allergen immunotherapyProtective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice.Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles.Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected miceGamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.Bioadhesive properties of pegylated nanoparticles.Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections.Nanoparticle based-immunotherapy against allergy.Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization.Nucleic acid vaccination strategies against infectious diseases.Interactions of poly (anhydride) nanoparticles with macrophages in light of their vaccine adjuvant properties.New pharmaceutical approaches for the treatment of food allergies.Adjuvants for allergy immunotherapeutics.Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine.Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.Nanocarriers with gentamicin to treat intracellular pathogens.Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock.BapA, a large secreted protein required for biofilm formation and host colonization of Salmonella enterica serovar Enteritidis.Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis.Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies.Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice.Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.Maternal Vaccination. Immunization of Sows during Pregnancy against ETEC Infections.Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis.Evaluation of nanoparticles as oral vehicles for immunotherapy against experimental peanut allergy.Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose.Chitosan/sulfated locust bean gum nanoparticles: In vitro and in vivo evaluation towards an application in oral immunization.Poly(anhydride) nanoparticles containing cashew nut proteins can induce a strong Th1 and Treg immune response after oral administration.Protective ability of subcellular extracts from Salmonella Enteritidis and from a rough isogenic mutant against salmonellosis in mice.Role of the GGDEF protein family in Salmonella cellulose biosynthesis and biofilm formation.The relationship between glycogen synthesis, biofilm formation and virulence in salmonella enteritidis.Development of a bacterial nanoparticle vaccine.Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery.
P50
Q26825418-48450571-344C-4C6A-B847-269C65636AA1Q33282108-3F475FCB-77D3-4F01-99A4-0CD8DC769224Q34057755-31913914-2692-4F06-9A06-54668E9F9212Q35758804-327D49C5-7841-425F-BA3B-9D958BE604EFQ35758859-28AE60F8-846E-4653-A0BE-86A782FD5B2DQ36316693-42875C08-C642-4A72-9C7A-79855121A826Q36969831-18CEA1C5-1BFD-410C-B3DE-99823E0C6B2FQ36985919-2F85809D-718E-4DB1-9229-10251DCDE93AQ38257645-9FB58CAD-87DF-44FF-BDE6-7C8003E39BC2Q38330161-CFAE56EB-FA5C-465E-9651-EA72AE20A181Q38586079-64982F15-7FD8-4FAE-A80E-9C8FBDE31B63Q38827842-271AA09B-3088-4E76-ADC6-F92C9135500FQ38978845-2BCC32BB-93EA-407E-98D0-8A5A0FF74EC4Q39151158-F9B96618-AFFA-42E8-8A22-76622BB0683BQ39341272-067D60BB-94BA-4BBA-9115-6271E750D33CQ39344545-B4A79DC8-27F4-4DDE-924C-8D61DACF745DQ40218706-2FE5DD13-89D3-4176-B933-3C7576594CCFQ40564034-9EFBEFE5-FAE7-41A2-8434-BB2900D47E7FQ40710906-07546D10-6873-4538-B03D-24C9A9114D22Q41194371-67DD4E5C-5D91-499F-AD2A-0609C9BDDA5CQ42674276-C58D19AC-9AF6-4D61-9BE3-E19E3FDAA259Q43196650-C2FE3753-832A-4569-806B-E932E95370B0Q43284750-3E0CF03B-84D4-4C4A-8EC3-9E30893E6874Q43792939-B3D8B96D-BDF5-43F6-9C9F-6676817D809FQ43962321-0141901B-E787-4991-B2C0-2D869ECB1F65Q44004231-D86CA8AE-AA58-427E-B59F-BE6B48260CD8Q44530950-F1F5F4BA-88B3-4311-8EAF-4451CBCE9F3AQ45962430-B5DCE09B-EDD1-4FE3-B6BB-4579A9095873Q46246924-0A17878D-31E2-4CE2-A71B-612054A1635FQ46446246-5FF0E807-F374-4529-BC7D-143060A873ABQ47410379-43B9F506-BBAB-40DF-A7C5-6C9B9449CF21Q47718781-444824C9-3D98-49E8-9093-42E6D24F7352Q48310893-79E54ED8-7E85-4FDA-9EFD-999EA2C573EAQ48881712-C09FFABC-1FAA-4A4B-B21D-CC2022ED16E7Q50080796-8959BCE1-99AF-4228-88BD-A3FFC0265992Q50093720-7ED660CF-64CF-49AA-A765-4FB3EF7AD8A2Q50096373-720AD49F-11EF-488F-97C1-A93A9A293D0BQ50119296-291019D7-941B-4329-AFA4-C569DB5E7D58Q50425048-399217DD-A519-458D-A44D-C5C415A2F4C7Q51186643-43713CB4-9A30-4D5D-87D4-33FFC3821A1A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlos Gamazo
@ast
Carlos Gamazo
@en
Carlos Gamazo
@es
Carlos Gamazo
@nl
type
label
Carlos Gamazo
@ast
Carlos Gamazo
@en
Carlos Gamazo
@es
Carlos Gamazo
@nl
prefLabel
Carlos Gamazo
@ast
Carlos Gamazo
@en
Carlos Gamazo
@es
Carlos Gamazo
@nl
P106
P1153
56269242200
P21
P31
P496
0000-0002-6586-4657